Strategies & Technologies Driving Drug Discovery to Market
Contract Formulation Company Profile - Glatt Air Techniques, Inc.
February 27, 2009 12:03 pm | Articles | CommentsGlatt Air Techniques is dedicated to the development of solid, oral dosage forms from pre-formulation studies through commercial scale, GMP production.
Contract Formulation Company Profile - Symyx Technologies Inc.
February 27, 2009 11:41 am | Articles | CommentsSymyx Technologies enables companies in life sciences to transform scientific R&D and achieve extraordinary breakthroughs in productivity and return on investment through expertise in scientific information management, microscale parallel experimentation, and contract research.
FDA Approves SYMBICORT
February 27, 2009 10:20 am | News | CommentsAstraZeneca announced that the FDA has approved SYMBICORT (budesonide/formoterol fumarate dihydrate).
HIV Adapts to ‘Escape’ Immune Response
February 27, 2009 10:09 am | News | CommentsThe human immunodeficiency virus (HIV) adapts so well to the body's defense system that any successful AIDS vaccine must keep pace with the ever-changing immunological profile of the virus.
Statins Lower Stroke Severity
February 27, 2009 8:15 am | News | CommentsMayo Clinic researchers have shown that patients who were taking statins before a stroke experienced better outcomes and recovery than patients who weren't on the drug.
FDA Calls GlaxoSmithKline’s Ad for Prostate Drug 'Misleading'
February 27, 2009 6:44 am | by Matthew Perrone, AP Business Writer | News | CommentsA marketing campaign for a GlaxoSmithKline prostate drug has drawn complaints from federal regulators, who said the space-themed advertisement is misleading.
Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220
February 27, 2009 4:42 am | News | CommentsAmicus Therapeutics announced that it has suspended enrollment for the Phase 2 clinical trial of its investigational drug AT2220.
Possible New Targets for Crohn's Disease Drugs Uncovered
February 27, 2009 4:29 am | News | CommentsUsing a novel approach that combines a statistical tool that identifies genes interacting on the same biological pathways with highly automated gene-hunting techniques that scan the whole genome, an international team of researchers has discovered new genes involved in Crohn's disease.
Antibiotic Combination Defeats Drug Resistant TB
February 27, 2009 4:18 am | News | CommentsA combination of two FDA-approved drugs, already approved for fighting other bacterial infections, shows potential for treating drug resistant tuberculosis (XDR-TB).
Drug Improves Mobility for Some MS Patients
February 27, 2009 4:06 am | News | CommentsThe experimental drug fampridine (4-aminopyridine) improves walking ability in some individuals with multiple sclerosis.
Endo Licenses Novel Pain Therapy from Grunenthal
February 27, 2009 3:53 am | News | CommentsEndo Pharmaceuticals announced that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug axomadol in the United States and Canada.
Immune Molecule Found that Attacks Wide Range of Flu Viruses
February 27, 2009 3:47 am | News | CommentsThe discovery of the molecule, an antibody known as CR6261, is good news for researchers who hope to design a flu vaccine that would give humans lifelong protection against a majority of influenza viruses.
Obama Calls for Generic Biotech Drugs
February 27, 2009 3:26 am | by Ricardo Alonso-Zaldivar, Associated Press Writer | News | CommentsPresident Barack Obama's budget aims to foster generic competition for costly biotech drugs used to treat cancer and other intractable ailments.
Abbott Completes Acquisition of Advanced Medical Optics
February 27, 2009 3:18 am | News | CommentsAbbott announced that it has completed its acquisition of Advanced Medical Optics.
FDA Slaps Warning On Heartburn Drug Tied To Spasms
February 27, 2009 3:11 am | by Associated Press | News | CommentsFederal health officials are adding their sternest warning to a heartburn drug that has been linked to muscle spasms.
